Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS

TXMD Stock Annual Income Statement. Download in Excel

TherapeuticsMD Inc. logo

TherapeuticsMD Inc.

Sector: Healthcare   

Industry: Drug Manufacturers - Major

1.11
 
USD
  
0.02
  
(1.83%)
Previous close: 1.09  Open: 1.1  Bid: 1.09  Ask: 1.2
52 week range    
1.05   
   2.75
Mkt Cap: 50 M  Avg Vol (90 Days): 18,703
Peers   
AGRX / 
LCI / 
RPRX / 
PFE / 
Last updated: Sunday 22nd December 2024

Stock Rankings

49
MarketXLS Rank
60
Value
38
Technical
50
Quality
How are these ranks calculated?
Search for a stock

Financials

TXMD Income Statement

Annual
Dec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22Dec-23
Amortization of intangibles-23480.0-32441.0-54545.0-71516.0-112474.05 M41 M7 M7 M6 M
Basic EPS from continuing operations-36.0-33.5-21.50.12-0.74
Basic EPS total-36.0-33.5-21.512.41-0.98
Basic weighted shares outstanding3 M3 M4 M4 M5 M5 M6 M8 M9 M10 M
BasicDiscontinuousOperations12.29-0.25
Cost of sales-4 M-5 M-4 M-3 M-3 M6 M16 M1 M1 M
Depreciation52467.062400.0132451.0213117.0293886.0612786.0800000.0400000.01 M922000.0
Depreciation unreconciled312494.062400.0132451.0213117.0293886.0612786.01 M1 M922000.0
DepreciationAndAmortization312494.062400.0132451.0213117.0293886.0612786.0800000.0400000.01 M922000.0
Diluted EPS total-18.0-24.5-23.0-18.5-29.5-36.0-33.5-21.511.95-0.98
Diluted normalized net income/share0.11-0.74
Diluted weighted shares outstanding3 M3 M4 M4 M4 M5 M8 M9 M10 M
DilutedDiscontinuousOperations11.84-0.25
GeneralAndAdministrativeExpense-361793.0-446099.0-709843.0-1 M-1 M174 M77 M81 M57 M9 M
Gross operating profit11 M16 M15 M14 M13 M43 M49 M1 M69 M1 M
Income before tax-54 M-85 M-90 M-77 M-133 M-176 M-184 M-79 M1 M-8 M
Income restructuring and M&A9 M
Income taxes-43000.0
Interest income37309.017442.010824.0
InterestExpenseNonOperating-1 M5 M17 M26 M23 M14 M300000.0
MiscOtherSpecialCharges46569.095719.0378141.0703330.02 M-8 M598000.0272000.0-117000.0781000.0
Net income from total operations-54 M-85 M-90 M-77 M-133 M-176 M-184 M-172 M112 M-10 M
NetIncomeCommonStockholders-54 M-85 M-90 M-77 M-133 M-176 M-184 M-79 M112 M-10 M
NetIncomeContinuousOperations-54 M-85 M-90 M-77 M-133 M-176 M-184 M-172 M1 M-8 M
NetIncomeDiscontinuousOperations-93 M111 M-3 M
NetNonOperatingInterestIncomeExpense37309.017442.010824.0-5 M-17 M-29 M-33 M-13 M-300000.0
Normalized income-63 M
Operating income-54 M-85 M-90 M-78 M-130 M-151 M-156 M-80 M11 M-9 M
Operating income before depreciation (EBITDA)-55 M-85 M-90 M-77 M-127 M-157 M-153 M-79 M12 M-7 M
OperatingExpense-65 M-101 M-105 M-92 M-144 M195 M204 M81 M58 M10 M
Other income net-46569.0-95719.0-378141.0-703330.0-2 M8 M-598000.0-272000.0-10 M-781000.0
OtherGainLossFromDispositionOfDiscontinuedOperations-93 M111 M-3 M
OtherGandA-361793.0-446099.0-709843.0-1 M-1 M174 M77 M81 M57 M9 M
OtherImpairmentOfCapitalAssets78864.01 M
OtherOperatingExpenses2 M2 M2 M2 M2 M
OtherWriteDown275379.0
OtherWriteOff24000.0317000.0
PromotionAndAdvertising-698871.0-792574.0-752611.0-448288.0-2 M9 M36 M40 M13 M
RentAndLandingFees-361793.0-446099.0-709843.0-1 M-1 M
Research & development expense43 M72 M54 M34 M27 M20 M10 M7 M
ResearchExpense43 M72 M54 M34 M27 M20 M10 M7 M
RestructringAndMnAIncome9 M
Revenue per share260027.0-32441.0-54545.0-71516.0-382333.06 M41 M7 M7 M6 M
SalariesAndWages-4 M-7 M-17 M-7 M-9 M11 M11 M-278000.012 M
Selling Gen & administrative expense22 M29 M51 M58 M116 M174 M194 M81 M57 M9 M
SellingAndMarketingExpense22 M29 M51 M58 M116 M9 M117 M40 M13 M
SellingExpense22 M29 M51 M58 M116 M
Special income/charges-9 M
Total Income available for interest expense (EBIT)-55 M-85 M-90 M-77 M-128 M-159 M-157 M-80 M11 M-7 M
Total common shares outstanding5 M4 M4 M4 M5 M5 M8 M9 M10 M
Total net income-54 M-85 M-90 M-77 M-133 M-176 M-184 M-172 M112 M-10 M
Total ordinary shares44 M44 M44 M44 M44 M44 M44 M44 M44 M44 M
Total revenues15 M20 M19 M17 M16 M50 M65 M3 M70 M1 M
TotalExpenses-69 M-105 M-110 M-94 M-146 M201 M220 M82 M59 M10 M
TotalRevenue15 M20 M19 M17 M16 M50 M65 M3 M70 M1 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University